ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
Greenandgold93
|
2.4K |
1.1M |
1 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
1
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
Greenandgold93
|
2.4K |
1.1M |
3 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
3
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
Greenandgold93
|
46 |
16K |
7 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
46
|
16K
|
7
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
Greenandgold93
|
46 |
16K |
27 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
46
|
16K
|
27
|
|
Charts
|
EMV |
Re:
Chart
|
|
Greenandgold93
|
2.7K |
1.5M |
4 |
04/03/24 |
04/03/24 |
Charts
|
2.7K
|
1.5M
|
4
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
Greenandgold93
|
2.4K |
1.1M |
6 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
6
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
Greenandgold93
|
2.4K |
1.1M |
5 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
5
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
Greenandgold93
|
2.4K |
1.1M |
6 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
6
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Strategic A$15.28M Investment from Keysight Technologies
|
|
Greenandgold93
|
33 |
12K |
26 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
33
|
12K
|
26
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
Greenandgold93
|
2.4K |
1.1M |
5 |
24/02/24 |
24/02/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
5
|
|
Charts
|
EMV |
Re:
Chart
|
|
Greenandgold93
|
2.7K |
1.5M |
3 |
19/02/24 |
19/02/24 |
Charts
|
2.7K
|
1.5M
|
3
|
|
Charts
|
EMV |
Re:
Chart
|
|
Greenandgold93
|
2.7K |
1.5M |
7 |
02/02/24 |
02/02/24 |
Charts
|
2.7K
|
1.5M
|
7
|
|
Charts
|
EMV |
Re:
Chart
|
|
Greenandgold93
|
2.7K |
1.5M |
4 |
30/01/24 |
30/01/24 |
Charts
|
2.7K
|
1.5M
|
4
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Change of Director's Interest Notice - M Ziirsen
|
|
Greenandgold93
|
1 |
419 |
3 |
21/01/24 |
21/01/24 |
ASX - By Stock
|
1
|
419
|
3
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
Greenandgold93
|
2.4K |
1.1M |
15 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
15
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
Greenandgold93
|
120 |
44K |
3 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
120
|
44K
|
3
|
|
ASX - By Stock
|
EMV |
Re:
AGM 2023
|
|
Greenandgold93
|
44 |
12K |
7 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
44
|
12K
|
7
|
|
ASX - By Stock
|
AGN |
Re:
Ann: ARG-007 Phase 2 Clinical Trial Update
|
|
Greenandgold93
|
7 |
2.9K |
3 |
19/07/23 |
19/07/23 |
ASX - By Stock
|
7
|
2.9K
|
3
|
|
Charts
|
EMV |
Re:
Chart
|
|
Greenandgold93
|
2.7K |
1.5M |
5 |
13/07/23 |
13/07/23 |
Charts
|
2.7K
|
1.5M
|
5
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Argenica Appoints CEO Dr Liz Dallimore Managing Director
|
|
Greenandgold93
|
5 |
2.6K |
4 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
5
|
2.6K
|
4
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl Announces Leadership Changes & Strategic Realignment
|
|
Greenandgold93
|
6 |
4.0K |
8 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
6
|
4.0K
|
8
|
|
ASX - By Stock
|
AGN |
Re:
Ann: ARG-007 Protects Brain Cells in Moderate TBI Model
|
|
Greenandgold93
|
19 |
6.6K |
7 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
19
|
6.6K
|
7
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl completes Placement and secures short term loan
|
|
Greenandgold93
|
2 |
823 |
0 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
2
|
823
|
0
|
|
Charts
|
EMV |
Re:
Chart
|
|
Greenandgold93
|
2.7K |
1.5M |
10 |
28/06/23 |
28/06/23 |
Charts
|
2.7K
|
1.5M
|
10
|
|
Charts
|
EMV |
Re:
Chart
|
|
Greenandgold93
|
2.7K |
1.5M |
10 |
27/06/23 |
27/06/23 |
Charts
|
2.7K
|
1.5M
|
10
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl appoints Dr Hugo Stephenson as Strategic Advisor
|
|
Greenandgold93
|
7 |
2.7K |
3 |
19/06/23 |
19/06/23 |
ASX - By Stock
|
7
|
2.7K
|
3
|
|
ASX - By Stock
|
EMV |
Re:
Vintage
|
|
Greenandgold93
|
9 |
4.0K |
16 |
17/06/23 |
17/06/23 |
ASX - By Stock
|
9
|
4.0K
|
16
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
Greenandgold93
|
2.4K |
1.1M |
11 |
13/06/23 |
13/06/23 |
ASX - By Stock
|
2.4K
|
1.1M
|
11
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Leadership Transition
|
|
Greenandgold93
|
95 |
28K |
9 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
95
|
28K
|
9
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Leadership Transition
|
|
Greenandgold93
|
95 |
28K |
5 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
95
|
28K
|
5
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Leadership Transition
|
|
Greenandgold93
|
95 |
28K |
12 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
95
|
28K
|
12
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Leadership Transition
|
|
Greenandgold93
|
95 |
28K |
16 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
95
|
28K
|
16
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 of Clinical Trial Activated
|
|
Greenandgold93
|
29 |
9.6K |
15 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
29
|
9.6K
|
15
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Change of Director's Interest Notice
|
|
Greenandgold93
|
4 |
1.3K |
0 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
4
|
1.3K
|
0
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Change of Director's Interest Notice
|
|
Greenandgold93
|
4 |
1.3K |
2 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
4
|
1.3K
|
2
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Change of Director's Interest Notice
|
|
Greenandgold93
|
4 |
1.3K |
3 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
4
|
1.3K
|
3
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl appoints Dr Hugo Stephenson as Strategic Advisor
|
|
Greenandgold93
|
7 |
2.7K |
4 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
7
|
2.7K
|
4
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Clinical Trial Stage 1 Enrolment Completed
|
|
Greenandgold93
|
46 |
12K |
9 |
21/02/23 |
21/02/23 |
ASX - By Stock
|
46
|
12K
|
9
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Clinical Trial Stage 1 Enrolment Completed
|
|
Greenandgold93
|
46 |
12K |
4 |
21/02/23 |
21/02/23 |
ASX - By Stock
|
46
|
12K
|
4
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Clinical Trial Stage 1 Enrolment Completed
|
|
Greenandgold93
|
46 |
12K |
5 |
21/02/23 |
21/02/23 |
ASX - By Stock
|
46
|
12K
|
5
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Clinical Trial Stage 1 Enrolment Completed
|
|
Greenandgold93
|
46 |
12K |
5 |
21/02/23 |
21/02/23 |
ASX - By Stock
|
46
|
12K
|
5
|
|
Charts
|
EMV |
Re:
Chart
|
|
Greenandgold93
|
2.7K |
1.5M |
5 |
08/02/23 |
08/02/23 |
Charts
|
2.7K
|
1.5M
|
5
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl enters into MSA and new clinical trial recruitment
|
|
Greenandgold93
|
5 |
2.7K |
3 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
5
|
2.7K
|
3
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl completes Placement and launches Rights Issue
|
|
Greenandgold93
|
9 |
5.0K |
1 |
05/01/23 |
05/01/23 |
ASX - By Stock
|
9
|
5.0K
|
1
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl completes Placement and launches Rights Issue
|
|
Greenandgold93
|
9 |
5.0K |
1 |
23/12/22 |
23/12/22 |
ASX - By Stock
|
9
|
5.0K
|
1
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Trading Halt
|
|
Greenandgold93
|
11 |
2.6K |
1 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
11
|
2.6K
|
1
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Trading Halt
|
|
Greenandgold93
|
11 |
2.6K |
3 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
11
|
2.6K
|
3
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
Greenandgold93
|
2.4K |
1.1M |
5 |
21/11/22 |
21/11/22 |
ASX - By Stock
|
2.4K
|
1.1M
|
5
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
Greenandgold93
|
2.4K |
1.1M |
1 |
21/11/22 |
21/11/22 |
ASX - By Stock
|
2.4K
|
1.1M
|
1
|
|
ASX - By Stock
|
EMV |
Re:
Random AGM notes & quotes
|
|
Greenandgold93
|
27 |
8.2K |
6 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
27
|
8.2K
|
6
|
|